Skip to main content
Top
Published in: BMC Public Health 1/2013

Open Access 01-12-2013 | Research article

Monitoring the profile of cervical cancer in a developing city

Authors: Fábio Marques de Almeida, José Carlos de Oliveira, Edésio Martins, Maria Paula Curado, Ruffo de Freitas Jr, Marise Amaral Rebouças Moreira

Published in: BMC Public Health | Issue 1/2013

Login to get access

Abstract

Background

Medical records are frequently consulted to verify whether the treatment and guiding principles were correct. Determine incidence and mortality trends of in situ and invasive neoplasms of the uterine cervix, in the period 1988–2004 in Goiânia, Brazil.

Methods

The incident cases were identified through the Population-Based Cancer Registry of Goiânia. Population data were collected from census data of the Brazilian Institute of Geography and Statistics. For mortality analysis, data were extracted from the Mortality Information System. The Poisson Regression was utilized to determine the annual incidence and mortality rates.

Results

A total of 4446 cases of in situ and invasive neoplasms of the uterine cervix were identified. No significant reductions were verified in invasive cervical cancer rates (p = 0.386) during the study period, while in situ carcinomas presented an annual increasing trend of 13.08% (p < 0.001). A decreasing trend was observed for mortality (3.02%, p = 0.017).

Conclusion

No reduction was observed for the incidence of invasive cancer of the uterine cervix; however, increasing trends were verified for in situ lesions with a consequent reduction in mortality rates. These increasing trends may be the result of recently-implemented screening programs or due to improvements in the notification system.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sankaranarayanan R, Gaffikin L, Jacob M, Sellors J, Robles S: A critical assessment of screening methods for cervical neoplasia. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2005, 89 (Suppl 2): S4-S12.CrossRef Sankaranarayanan R, Gaffikin L, Jacob M, Sellors J, Robles S: A critical assessment of screening methods for cervical neoplasia. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2005, 89 (Suppl 2): S4-S12.CrossRef
2.
go back to reference Brasil: Ministério da Saúde. Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Estimativa 2012 - Incidência de Câncer no Brasil. 2011, Rio de Janeiro, RJ: Flama Brasil: Ministério da Saúde. Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Estimativa 2012 - Incidência de Câncer no Brasil. 2011, Rio de Janeiro, RJ: Flama
5.
go back to reference Brasil: Ministério da Saúde. do Câncer e Fatores de Risco. Secretaria Nacional de Assistência à Saúde. Instituto Nacional de Câncer (INCA). Atlas de Mortalidade por Câncer, vol. 2013. 2013, Rio de Janeiro, RJ: Comprev Brasil: Ministério da Saúde. do Câncer e Fatores de Risco. Secretaria Nacional de Assistência à Saúde. Instituto Nacional de Câncer (INCA). Atlas de Mortalidade por Câncer, vol. 2013. 2013, Rio de Janeiro, RJ: Comprev
7.
go back to reference Denny L: Cervical cancer: prevention and treatment. Discov Med. 2012, 14 (75): 125-131.PubMed Denny L: Cervical cancer: prevention and treatment. Discov Med. 2012, 14 (75): 125-131.PubMed
8.
go back to reference Brasil: Ministério da Saúde. Secretária de Assistência à Saúde. Instituto Nacional de Câncer. Viva mulher. Câncer do cólo do útero: informações técnico-gerenciais e ações desenvolvidas, Ministério da Saúde edn. 2002, Rio de Janeiro: Ministério da Saúde Brasil: Ministério da Saúde. Secretária de Assistência à Saúde. Instituto Nacional de Câncer. Viva mulher. Câncer do cólo do útero: informações técnico-gerenciais e ações desenvolvidas, Ministério da Saúde edn. 2002, Rio de Janeiro: Ministério da Saúde
9.
go back to reference Brasil: Ministério da Saúde: Portaria n°. 493, de 10 de março de 2006. Aprova a Relação de Indicadores da Atenção Básica – 2006, cujos indicadores deverão ser pactuados entre municípios, estados e o Ministério da Saúde. 2006, Brasilia: Ministério da Saúde: Diário Oficial da União Brasil: Ministério da Saúde: Portaria n°. 493, de 10 de março de 2006. Aprova a Relação de Indicadores da Atenção Básica – 2006, cujos indicadores deverão ser pactuados entre municípios, estados e o Ministério da Saúde. 2006, Brasilia: Ministério da Saúde: Diário Oficial da União
10.
go back to reference Pinho A, França Júnior I, Schraiber L, D’oliveira A: Cobertura e motivos para a realização ou não do teste de Papanicolaou no Município de São Paulo. Cad Saude Publica. 2003, 19 (S2): S303-S313.CrossRef Pinho A, França Júnior I, Schraiber L, D’oliveira A: Cobertura e motivos para a realização ou não do teste de Papanicolaou no Município de São Paulo. Cad Saude Publica. 2003, 19 (S2): S303-S313.CrossRef
11.
go back to reference Quadros C, Victora C, Dias-da-Costa J: Coverage and focus of a cervical cancer prevention program in Southern Brazil. Rev Panam Salud Publica. 2004, 16 (4): 223-232.CrossRefPubMed Quadros C, Victora C, Dias-da-Costa J: Coverage and focus of a cervical cancer prevention program in Southern Brazil. Rev Panam Salud Publica. 2004, 16 (4): 223-232.CrossRefPubMed
12.
go back to reference Bleggi Torres LF, Werner B, Totsugui J, Collaco LM, Araujo SR, Huculak M, Boza EJ, Fischer RM, De Laat L, Sobbania LC, et al: Cervical cancer screening program of Parana: cost-effective model in a developing country. Diagn Cytopathol. 2003, 29 (1): 49-54. 10.1002/dc.10269.CrossRefPubMed Bleggi Torres LF, Werner B, Totsugui J, Collaco LM, Araujo SR, Huculak M, Boza EJ, Fischer RM, De Laat L, Sobbania LC, et al: Cervical cancer screening program of Parana: cost-effective model in a developing country. Diagn Cytopathol. 2003, 29 (1): 49-54. 10.1002/dc.10269.CrossRefPubMed
13.
go back to reference ICCFACC. International Consensus Conference on the Fight Against Cervical Cancer: Features of successful organized screening programs. International Consensus Conference on the Fight Against Cervical Cancer: March 22, 2000. 2000, Chicago ICCFACC. International Consensus Conference on the Fight Against Cervical Cancer: Features of successful organized screening programs. International Consensus Conference on the Fight Against Cervical Cancer: March 22, 2000. 2000, Chicago
14.
go back to reference Anttila A, Pukkala E, Soderman B, Kallio M, Nieminen P, Hakama M: Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963–1995: recent increase in cervical cancer incidence. Int J Cancer. 1999, 83 (1): 59-65. 10.1002/(SICI)1097-0215(19990924)83:1<59::AID-IJC12>3.0.CO;2-N.CrossRefPubMed Anttila A, Pukkala E, Soderman B, Kallio M, Nieminen P, Hakama M: Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963–1995: recent increase in cervical cancer incidence. Int J Cancer. 1999, 83 (1): 59-65. 10.1002/(SICI)1097-0215(19990924)83:1<59::AID-IJC12>3.0.CO;2-N.CrossRefPubMed
15.
go back to reference Peto J, Gilham C, Fletcher O, Matthews FE: The cervical cancer epidemic that screening has prevented in the UK. Lancet. 2004, 364 (9430): 249-256. 10.1016/S0140-6736(04)16674-9.CrossRefPubMed Peto J, Gilham C, Fletcher O, Matthews FE: The cervical cancer epidemic that screening has prevented in the UK. Lancet. 2004, 364 (9430): 249-256. 10.1016/S0140-6736(04)16674-9.CrossRefPubMed
16.
go back to reference Sigurdsson K, Sigvaldason H: Effectiveness of cervical cancer screening in Iceland, 1964–2002: a study on trends in incidence and mortality and the effect of risk factors. Acta Obstet Gynecol Scand. 2006, 85 (3): 343-349. 10.1080/00016340500432457.CrossRefPubMed Sigurdsson K, Sigvaldason H: Effectiveness of cervical cancer screening in Iceland, 1964–2002: a study on trends in incidence and mortality and the effect of risk factors. Acta Obstet Gynecol Scand. 2006, 85 (3): 343-349. 10.1080/00016340500432457.CrossRefPubMed
17.
go back to reference Bray F, Carstensen B, Moller H, Zappa M, Zakelj MP, Lawrence G, Hakama M, Weiderpass E: Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev. 2005, 14 (9): 2191-2199. 10.1158/1055-9965.EPI-05-0231.CrossRefPubMed Bray F, Carstensen B, Moller H, Zappa M, Zakelj MP, Lawrence G, Hakama M, Weiderpass E: Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev. 2005, 14 (9): 2191-2199. 10.1158/1055-9965.EPI-05-0231.CrossRefPubMed
18.
go back to reference Gustafsson L, Ponten J, Zack M, Adami HO: International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control. 1997, 8 (5): 755-763. 10.1023/A:1018435522475.CrossRefPubMed Gustafsson L, Ponten J, Zack M, Adami HO: International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control. 1997, 8 (5): 755-763. 10.1023/A:1018435522475.CrossRefPubMed
19.
go back to reference Quinn M, Babb P, Jones J, Allen E: Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ. 1999, 318 (7188): 904-908. 10.1136/bmj.318.7188.904.CrossRefPubMedPubMedCentral Quinn M, Babb P, Jones J, Allen E: Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ. 1999, 318 (7188): 904-908. 10.1136/bmj.318.7188.904.CrossRefPubMedPubMedCentral
20.
go back to reference WHO - World Health Organization: Comprehensive cervical cancer control: a guide to essential practice. 2006, Switzerland: Publications of the World Health Organization WHO - World Health Organization: Comprehensive cervical cancer control: a guide to essential practice. 2006, Switzerland: Publications of the World Health Organization
21.
go back to reference Brenna SM, Hardy E, Zeferino LC, Namura I: Knowledge, attitudes, and practices related to the Pap smear among women with cervical cancer. Cad Saude Publica. 2001, 17 (4): 909-914. 10.1590/S0102-311X2001000400024.CrossRefPubMed Brenna SM, Hardy E, Zeferino LC, Namura I: Knowledge, attitudes, and practices related to the Pap smear among women with cervical cancer. Cad Saude Publica. 2001, 17 (4): 909-914. 10.1590/S0102-311X2001000400024.CrossRefPubMed
22.
go back to reference Freitas RA, Carvasan GA, Morais SS, Zeferino LC: Excessive Pap smears due to opportunistic cervical cancer screening. Eur J Gynaecol Oncol. 2008, 29 (5): 479-482.PubMed Freitas RA, Carvasan GA, Morais SS, Zeferino LC: Excessive Pap smears due to opportunistic cervical cancer screening. Eur J Gynaecol Oncol. 2008, 29 (5): 479-482.PubMed
23.
go back to reference Kalakun L, Bozzetti MC: Evolution of uterine cervical cancer mortality from 1979 to 1998 in the State of Rio Grande do Sul. Brazil. Cad Saúde Pública. 2005, 21 (1): 299-309.CrossRefPubMed Kalakun L, Bozzetti MC: Evolution of uterine cervical cancer mortality from 1979 to 1998 in the State of Rio Grande do Sul. Brazil. Cad Saúde Pública. 2005, 21 (1): 299-309.CrossRefPubMed
24.
go back to reference Alves CM, Guerra MR, Bastos RR: Cervical cancer mortality trends in Minas Gerais State, Brazil, 1980–2005. Cad Saude Publica. 2009, 25 (8): 1693-1700. 10.1590/S0102-311X2009000800005.CrossRefPubMed Alves CM, Guerra MR, Bastos RR: Cervical cancer mortality trends in Minas Gerais State, Brazil, 1980–2005. Cad Saude Publica. 2009, 25 (8): 1693-1700. 10.1590/S0102-311X2009000800005.CrossRefPubMed
25.
go back to reference Arbyn M, Geys H: Trend of cervical cancer mortality in Belgium (1954–1994): tentative solution for the certification problem of unspecified uterine cancer. Int J Cancer. 2002, 102 (6): 649-654. 10.1002/ijc.10761.CrossRefPubMed Arbyn M, Geys H: Trend of cervical cancer mortality in Belgium (1954–1994): tentative solution for the certification problem of unspecified uterine cancer. Int J Cancer. 2002, 102 (6): 649-654. 10.1002/ijc.10761.CrossRefPubMed
26.
go back to reference Fonseca LA, Ramacciotti Ade S, Eluf Neto J: Mortality trends from uterine cervical cancer in the city of Sao Paulo from 1980 to 1999. Cad Saude Publica. 2004, 20 (1): 136-142. 10.1590/S0102-311X2004000100029.CrossRefPubMed Fonseca LA, Ramacciotti Ade S, Eluf Neto J: Mortality trends from uterine cervical cancer in the city of Sao Paulo from 1980 to 1999. Cad Saude Publica. 2004, 20 (1): 136-142. 10.1590/S0102-311X2004000100029.CrossRefPubMed
27.
go back to reference Monk BJ, Tewari KS, Koh WJ: Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions. J Clin Oncol. 2007, 25 (20): 2952-2965. 10.1200/JCO.2007.10.8324.CrossRefPubMed Monk BJ, Tewari KS, Koh WJ: Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions. J Clin Oncol. 2007, 25 (20): 2952-2965. 10.1200/JCO.2007.10.8324.CrossRefPubMed
28.
go back to reference Mendonça VG, Lorenzato FRB, Mendonça JG, Menezes TC, Guimarães MJB: Mortalidade por câncer do colo do útero: características sociodemográficas das mulheres residentes na cidade de Recife, Pernambuco. Rev Bras Ginecol Obstet. 2008, 30: 248-255.CrossRefPubMed Mendonça VG, Lorenzato FRB, Mendonça JG, Menezes TC, Guimarães MJB: Mortalidade por câncer do colo do útero: características sociodemográficas das mulheres residentes na cidade de Recife, Pernambuco. Rev Bras Ginecol Obstet. 2008, 30: 248-255.CrossRefPubMed
29.
go back to reference Negri G, Romano F, Vittadello F, Kasal A, Mazzoleni G, Colombetti V, Egarter-Vigl E: Laminin-5 gamma2 chain immunohistochemistry facilitates the assessment of invasiveness and improves the diagnostic reproducibility of glandular lesions of the cervix uteri. Hum Pathol. 2006, 37 (6): 704-710. 10.1016/j.humpath.2006.01.020.CrossRefPubMed Negri G, Romano F, Vittadello F, Kasal A, Mazzoleni G, Colombetti V, Egarter-Vigl E: Laminin-5 gamma2 chain immunohistochemistry facilitates the assessment of invasiveness and improves the diagnostic reproducibility of glandular lesions of the cervix uteri. Hum Pathol. 2006, 37 (6): 704-710. 10.1016/j.humpath.2006.01.020.CrossRefPubMed
30.
go back to reference Shin HR, Curado MP, Ferlay J, Heanue M, Edwards B, Storm H: Comparability and quality of data. Cancer Incidence in Five Continents. Volume IX. Edited by: Curado MP. 2007, Lyon, France: IARC Scientific Publications, 160-1 Shin HR, Curado MP, Ferlay J, Heanue M, Edwards B, Storm H: Comparability and quality of data. Cancer Incidence in Five Continents. Volume IX. Edited by: Curado MP. 2007, Lyon, France: IARC Scientific Publications, 160-1
31.
go back to reference Oliveira M, Antônio M, Luciane M, Liberata C: Cobertura e fatores associados a não realização do exame preventivo de Papanicolaou em São Luís. Maranhão. Rev Bras Epidemiol. 2006, 9 (3): 325-334. Oliveira M, Antônio M, Luciane M, Liberata C: Cobertura e fatores associados a não realização do exame preventivo de Papanicolaou em São Luís. Maranhão. Rev Bras Epidemiol. 2006, 9 (3): 325-334.
32.
go back to reference Lazcano-Ponce E, Palacio-Mejia LS, Allen-Leigh B, Yunes-Diaz E, Alonso P, Schiavon R, Hernandez-Avila M: Decreasing cervical cancer mortality in Mexico: effect of Papanicolaou coverage, birthrate, and the importance of diagnostic validity of cytology. Cancer Epidemiol Biomarkers Prev. 2008, 17 (10): 2808-2817. 10.1158/1055-9965.EPI-07-2659.CrossRefPubMed Lazcano-Ponce E, Palacio-Mejia LS, Allen-Leigh B, Yunes-Diaz E, Alonso P, Schiavon R, Hernandez-Avila M: Decreasing cervical cancer mortality in Mexico: effect of Papanicolaou coverage, birthrate, and the importance of diagnostic validity of cytology. Cancer Epidemiol Biomarkers Prev. 2008, 17 (10): 2808-2817. 10.1158/1055-9965.EPI-07-2659.CrossRefPubMed
Metadata
Title
Monitoring the profile of cervical cancer in a developing city
Authors
Fábio Marques de Almeida
José Carlos de Oliveira
Edésio Martins
Maria Paula Curado
Ruffo de Freitas Jr
Marise Amaral Rebouças Moreira
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2013
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-13-563

Other articles of this Issue 1/2013

BMC Public Health 1/2013 Go to the issue